Bibliometric Analysis of Global Scientific Production on COVID-19 and Vaccines

• Published in: International journal of environmental research and public health 2023-03, Vol.20 (6), p.4796
• Main Authors: Sousa Neto, Antonio Rosa de, Carvalho, Ana Raquel Batista de, Ferreira da Silva, Márcia Daiane, Rêgo Neta, Marly Marques, Sena, Inara Viviane de Oliveira, Almeida, Rosângela Nunes, Filha, Francidalma Soares Sousa Carvalho, Lima E Silva, Laianny Luize, Costa, Girlene Ribeiro da, Lira, Ivana Mayra da Silva, Portela, Denise Maria Meneses Cury, Oliveira E Silva, Amanda Tauana, Rabêlo, Cristiane Borges de Moura, Valle, Andreia Rodrigues Moura da Costa, Moura, Maria Eliete Batista, Freitas, Daniela Reis Joaquim de
• Format: Article
• Language: English
• Subjects: Acceptance tests; Analysis; Bibliometrics; Collaboration; Coronaviruses; COVID-19; COVID-19 - prevention & control; COVID-19 vaccines; COVID-19 Vaccines - therapeutic use; Database industry; Government agencies; Humans; International economic relations; Keywords; Medical research; Medicine, Experimental; Metadata; Pharmaceutical industry; Researchers; Severe acute respiratory syndrome coronavirus 2; Software; Vaccination; Vaccines
• ISSN: 1660-4601; 1661-7827; 1660-4601
• DOI: 10.3390/ijerph20064796

This bibliometric analysis aims to analyze the global scientific production of COVID-19 and vaccines. First, a search for scientific articles was performed using the advanced query in the Web of Science™ database, more precisely in its core collection, on 18 February 2023. Data from 7754 articles were analyzed using the Bibliometrix R package and the Biblioshiny application. The evaluated articles were published mainly in 2022 (60%). The scientific journals that published the most about COVID-19 and vaccines were "Vaccines", "Vaccine" and "Human Vaccines & Immunotherapeutics". The University of Oxford was the most productive institution, with the authors of the articles mainly originating from the United States, China and the United Kingdom. The United States, despite having carried out the most significant number of collaborations, published mainly with local researchers. The 15 most cited articles and the KeyWords Plus™ evidenced the focus of the published articles on the safety and efficacy of vaccines against COVID-19, as well as on the evaluation of vaccine acceptance, more specifically on vaccine hesitancy. Research funding came primarily from US government agencies.